~0 spots leftby Apr 2026

Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States

Recruiting in Palo Alto (17 mi)
RJ
Overseen byRobert J Volk
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: M.D. Anderson Cancer Center
No Placebo Group

Trial Summary

What is the purpose of this trial?

This study better understands the views on shared decision-making among Chinese adults who smoke or who have a spouse who smokes. Lung cancer is the second most common cancer among men and women in the United States and is the number one cause of cancer-related mortality among Asians and Pacific Islanders. Clinicians are recommended to initiate conversations about lung cancer screening with eligible patients, provide information about the benefits and harms, and engage in shared decision-making. However, a patient's cultural background can influence decision-making in many ways. Given this, there is a need to understand the perceptions of shared decision-making among different populations (in this case, Asian populations) in order to inform the design of culturally sensitive decision aids for cancer screening. This study evaluates how Chinese populations in the U.S. who currently smoke or who have partners who smoke perceive the process of shared decision-making, their preferences, the perceived barriers and facilitators, and their perspective on currently-available screening tools.

Research Team

RJ

Robert J Volk

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

Inclusion Criteria

Speak English and/or Mandari
Men and women who self-identify as Chinese
Live in the U.S. (either citizens or have lived in the U.S. for at least 5 years or more, i.e. long-term residents)
See 2 more

Treatment Details

Interventions

  • Shared Decision-Making (N/A)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Observational (interview, discussion)Experimental Treatment2 Interventions
Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3107
Patients Recruited
1,813,000+